Express Scripts Maintains Antitrust OK Within Reach

Law360, New York (March 9, 2007, 12:00 AM EST) -- Though Caremark’s board has voiced antitrust concerns, pharmacy benefits manager Express Scripts Inc. insists that its hostile takeover offer for the rival can secure regulatory approval in time.

On Thursday, Express Scripts said in a filing with the U.S. Securities & Exchange Commission that the company remained confident that it would “clear antitrust in a timely manner.”

The filing remarks surfaced on the same day that Caremark’s board chose to throw its support behind CVS’ sweetened bid amid worries that Express Scripts’ proposal would likely trigger...
To view the full article, register now.